ACO1 · Western blot design guide

ACO1 Western Blot Planning Guide

Plan an ACO1 Western blot around the catalog-observed 98.4 kDa band, image-backed A02781-1 evidence, HPA controls, and verified protocol records.

Evidence assembled July 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for ACO1 (ACO1): expected band 98.4 kDa, antibody A02781-1, and guide-derived SDS-PAGE protocol steps
ACO1 Western blot protocol sheet — expected band 98.4 kDa, antibody A02781-1, controls and PMC citations. Open the full ACO1 WB guide →

ACO1 Western Blot Experimental Design Guide

Expected bands, documented protocol parameters, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band 98.4 kDa
Observed band Not reported — verify product WB image
Gel 8-10%
Positive control ⓘ Adipose tissue
Negative control ⓘ Bone marrow
Important caveats
Reasons your observed band may differ from the expected size.
ⓘ Calculated mass 98.4 kDa
ⓘ Localization Cytoplasm, cytosol
ⓘ Processing / PTM Record-dependent
ⓘ Reactivity Human / Mouse / Rat
Section 1

Real Curated ACO1 Western Blot Protocols

Start with the molecular-weight rule, then compare verified publication-derived conditions.

Recommended Western blot protocol parameters
Sample / lysateAdipose tissue
Gel %8-10%
Load20-30 µg total protein per lane
TransferSemi-dry, standard transfer
Membrane0.45 µm PVDF
Blocking5% non-fat milk or 5% BSA in TBST
PrimaryA02781-1 at datasheet starting dilution
Primary incubationOvernight at 4 °C with gentle agitation
SecondarySpecies-matched HRP conjugate at validated dilution
Wash3 × 5 min in TBST
DetectionChemiluminescent substrate
ExposureBracket exposures to avoid saturation
Section 2

What Is the Expected ACO1 Western Blot Band Size?

Use the product-observed 98.4 kDa band as the primary planning value and retain the UniProt calculated mass as context.

What am I looking at on my blot?
98.4 kDaMatches the authoritative product WB observation.
98.4 kDa calculatedUse as UniProt context, not as a replacement observed band.
Unexpected additional signalDo not assign identity without orthogonal positive/negative controls.
💡Expected ACO1 appearancePlan around 98.4 kDa and keep the calculated mass as supporting context.
How each factor affects band size
Catalog-observed band98.4 kDa; use this as the primary experimental expectation.
Calculated mass98.4 kDa from UniProt P21399; retain as context.
Gel selection8-10%; shared with the recommended protocol and poster.
Specificity checkCompare the lead HPA positive and negative controls with A02781-1.
Why is my band missing or off?
SituationLikely causeNext action
98.4 kDaMatches the authoritative product WB observation.Confirm with orthogonal controls and the linked product record.
Additional bandMay reflect processing, modification, or non-specific signal.Run a dilution series and compare positive/negative controls.
Weak signalTarget abundance or transfer may be limiting.Verify transfer, increase positive-control abundance, and bracket exposure.

Sample controls for ACO1 Western blot

🧪Use Adipose tissue as the first positive-control candidate and Bone marrow as the HPA Not detected negative candidate.
Positive control: Adipose tissue (High)
Negative control: Bone marrow (Not detected)
HPA protein score determines control status; other expression data is supporting context only.

HPA tissue expression evidence for ACO1

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Positive expression · recommended positive controls

TissueCell typeLevelEvidenceSource
Adipose tissue Reported tissue cells High Protein (HPA) HPA →
Stomach Reported tissue cells High Protein (HPA) HPA →
Kidney Reported tissue cells High Protein (HPA) HPA →
Small intestine Reported tissue cells High Protein (HPA) HPA →

Undetected expression · recommended negative controls

TissueCell typeLevelEvidenceSource
Bone marrow Reported tissue cells Not detected Protein (HPA) HPA →
Bronchus Reported tissue cells Not detected Protein (HPA) HPA →
Section 3

Advanced ACO1 Western Blot Tips

Deeper troubleshooting and optimisation questions for ACO1, answered from its protein features.

Which band should guide the blot?
Use 98.4 kDa, the observation attached to the authoritative A02781-1 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 98.4 kDa expectation.
Which positive control should I start with?
Start with Adipose tissue, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use Bone marrow as an orthogonal HPA Not detected candidate.
Which gel should I use?
Use 8-10% consistently across the quick facts, protocol table, and poster.
What transfer method to use for ACO1 Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should A02781-1 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
No verified publication protocol was supplied; use only the deterministic recommended protocol.
Boster reagents

ACO1 Western Blot Reagents

Human/Mouse/Rat-reactive ACO1 Western blot reagents with authoritative product imagery.

Real WB data Western blot validation image for ACO1 using A02781-1; observed band 98.4 kDa
Anti-Aconitase 1/ACO1 Antibody Picoband®
Cat # A02781-1

Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.

Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.

References

  1. UniProt P21399
  2. Human Protein Atlas — ACO1
  3. A02781-1 product record
  4. PMC12857413 — Pathological frataxin deficiency in mice causes tissue-specific alterations in iron homeostasis (iScience, 2026)
  5. PMC6461893 — Brivanib in combination with Notch3 silencing shows potent activity in tumour models (British journal of cancer, 2019)
  6. PMC11106963 — Diurnal control of iron responsive element containing mRNAs through iron regulatory proteins IRP1 and IRP2 is mediated by feeding rhythms (Genome biology, 2024)